Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.4B | 10.5B | 10.3B | 10.1B |
Cost of revenue | 5.3B | 5.4B | 5.1B | 5.3B |
Gross profit | 5.1B | 5.1B | 5.2B | 4.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.7B | 2.7B | 3.0B | 2.8B |
Operating income | 1.1B | 985.3M | 849.7M | 706.5M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 139.1M | 123.9M | 150.7M | 142.7M |
Other income expense | — | — | — | — |
Pretax income | 1.0B | 955.8M | 802.2M | 660.3M |
Tax provision | 277.3M | 262M | 212.2M | 172.9M |
Net income | 740.5M | 693.8M | 590M | 487.4M |
Basic EPS | — | 4.4 | 3.7 | 3.1 |
Diluted EPS | — | 4.4 | 3.7 | 3.1 |
Basic average shares | — | 158.0M | 158.2M | 158.2M |
Diluted average shares | — | 158.0M | 158.2M | 158.2M |
EBITDA | 1.6B | 1.5B | 1.3B | 1.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |